| Pre-Clinical pharmacokinetic and pharmacodynamic characterization of selected chiral flavonoids: pinocembrin and pinostrobin CL Sayre, S Alrushaid, SE Martinez, HD Anderson, NM Davies Journal of Pharmacy & Pharmaceutical Sciences 18 (4), 368-395, 2015 | 46 | 2015 |
| Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative S Alrushaid, CL Sayre, JA Yáñez, ML Forrest, SN Senadheera, ... Pharmaceutics 9 (3), 35, 2017 | 35 | 2017 |
| Disposition, Metabolism and Histone Deacetylase and Acetyltransferase Inhibition Activity of Tetrahydrocurcumin and Other Curcuminoids JT Novaes, R Lillico, CL Sayre, K Nagabushanam, M Majeed, Y Chen, ... Pharmaceutics 9 (4), 45, 2017 | 25 | 2017 |
| Therapeutic impact of orally administered cannabinoid oil extracts in an experimental autoimmune encephalomyelitis animal model of multiple sclerosis T Zhou, TK Ahmad, S Alrushaid, M Pozdirca, K Ethans, H Intrater, T Le, ... Biochemical and Biophysical Research Communications, 2019 | 17 | 2019 |
| Calebin A: Analytical Development for Pharmacokinetics Study, Elucidation of Pharmacological Activities and Content Analysis of Natural Health Products ALP Oliveira, SE Martinez, K Nagabushnam, M Majeed, S Alrushaid, ... Journal of Pharmacy & Pharmaceutical Sciences 18 (4), 494-514, 2015 | 16 | 2015 |
| Validation of Cadherin HAV6 Peptide in the Transient Modulation of the Blood-Brain Barrier for the Treatment of Brain Tumors BV Sajesh, NH On, R Omar, S Alrushaid, BM Kopec, WG Wang, HD Sun, ... Pharmaceutics 11 (9), 481, 2019 | 15 | 2019 |
| DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways Z Maayah, T Zhang, M Forrest, S Alrushaid, M Doschak, N Davies, ... Pharmaceutics 10 (3), 144, 2018 | 14 | 2018 |
| Pharmacological characterization of liquiritigenin, a chiral flavonoid in licorice S Alrushaid, NM Davies, SE Martinez, CL Sayre Research in pharmaceutical sciences 11 (5), 355, 2016 | 14 | 2016 |
| Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative S Alrushaid, Y Zhao, CL Sayre, ZH Maayah, ML Forrest, SN Senadheera, ... Drug delivery and translational research 7 (4), 582-597, 2017 | 13 | 2017 |
| Inhibition of BMP4 and Alpha Smooth Muscle Actin Expression in LX-2 Hepatic Stellate Cells by BMP4-siRNA Lipid Based Nanoparticle R Omar, J Yang, S Alrushaid, FJ Burczynski, GY Minuk, Y Gong Journal of Pharmacy & Pharmaceutical Sciences 21, 119-134, 2018 | 11 | 2018 |
| Pharmaceutical Characterization of MyoNovin, a Novel Skeletal Muscle Regenerator: in silico, in vitro and in vivo Studies S Alrushaid, NM Davies, JE Anderson, T Le, JA Yáñez, ZH Maayah, ... Journal of Pharmacy & Pharmaceutical Sciences 21 (1s), 1-18s, 2018 | 8 | 2018 |
| Chemical reactivity and microbicidal action of bethoxazin GL Chee, B Bhattarai, RD Gietz, S Alrushaid, JL Nitiss, BB Hasinoff Bioorganic & medicinal chemistry 20 (4), 1494-1501, 2012 | 8 | 2012 |
| Simultaneous quantification of reparixin and paclitaxel in plasma and urine using ultra performance liquid chromatography-tandem mass spectroscopy (UHPLC–MS/MS): Application to … S Malhi, N Stesco, S Alrushaid, TM Lakowski, NM Davies, X Gu Journal of Chromatography B 1046, 165-171, 2017 | 5 | 2017 |
| Stereospecific pharmacokinetic characterization of liquiritigenin in the rat S Alrushaid, NM Davies, SE Martinez, CL Sayre Research in pharmaceutical sciences 12 (3), 176, 2017 | 3 | 2017 |
| PEROXIREDOXIN1 IS A THERAPEUTIC TARGET IN GROUP-3 MEDULLOBLASTOMA B Sajesh, N On, R Omar, H Fediuk, L Li, S Alrushaid, W Wang, J Pu, ... NEURO-ONCOLOGY 20, 139-139, 2018 | 1 | 2018 |
| Pharmaceutical characterization of selected xenobiotics utilizing novel drug delivery systems S Alrushaid | 1 | 2018 |
| Correction to: Mechanistically elucidating the in vitro safety and efficacy of a novel doxorubicin derivative. S Alrushaid, Y Zhao, CL Sayre, ZH Maayah, ML Forrest, SN Senadheera, ... Drug delivery and translational research 8 (5), 1592, 2018 | | 2018 |
| 18 Peroxiredoxin1 is a therapeutic target in group-3 medulloblastoma BV Sajesh, OH Ngoc, R Omar, H Fediuk, L Li, S Alrushaid, W Wang, J Pu, ... Canadian Journal of Neurological Sciences 45 (S3), S16-S16, 2018 | | 2018 |
| Exth-80. Enhanced Therapeutic Response In Murine Medulloblastoma Tumor Model Using Adenanthin And Transient Modulation Of The Blood-brain Barrier With Cadherin Peptide NH On, S Babu, R Omar, S Alrushaid, Y Wang, JX Pu, HD Sun, N Davies, ... Neuro-oncology 19 (suppl_6), vi90-vi90, 2017 | | 2017 |
| Chemical reactivity and biological activity of bethoxazin, an industrial microbicide S Alrushaid Bioorganic & Medicinal Chemistry, 2012 | | 2012 |
Neal DaviesDean of PharmacyVerified email at ualberta.ca
